• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A novel mechanism of the peritoneal dissemination via multiple network among cellular skeleton-related molecules in ovarian cancer

Research Project

Project/Area Number 15K15604
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Obstetrics and gynecology
Research InstitutionNagoya University

Principal Investigator

Kajiyama Hiroaki  名古屋大学, 医学系研究科, 准教授 (00345886)

Co-Investigator(Renkei-kenkyūsha) SENGA Takeshi  名古屋大学, 大学院医学系研究科, 准教授 (80419431)
Project Period (FY) 2015-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords卵巣癌 / 腹膜播種 / 腹膜中皮細胞 / 腹膜間隙透過性 / filopodia形成 / 細胞コミュニケーション / アクチンモーター蛋白 / 浸潤
Outline of Final Research Achievements

Epithelial ovarian carcinoma (EOC) is believed to cause peritoneum dissemination through microenvironmental cell-to-cell communication between the tumor and mesothelium, leading to the further acquisition of progressive and metastatic potentials. In the present study, we aimed to determine the role of cancer-associated mesothelial cells (CAMCs) in the maintenance of cisplatin-resistance. Normal mesothelium (MC) showed an epithelial morphology with a cobblestone appearance. When MCs were co-cultured with malignant ascites from patients with advanced EOC, a dramatic morphologic change was noted from an epithelioid pattern to a-SMA-positive fibroblastic, mesenchymal pattern. Our findings indicate the possible involvement of CAMCs in the maintenance of cisplatin-resistance, resulting in being “seeds of recurrence”. The novel mechanism of CAMCs as a facilitator of EOC progression is displayed through microenvironmental cell-to-cell communication between EOC and the mesothelium.

Report

(3 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • Research Products

    (7 results)

All 2017 2016 2015

All Journal Article (7 results) (of which Peer Reviewed: 7 results,  Open Access: 7 results,  Acknowledgement Compliant: 1 results)

  • [Journal Article] Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.2017

    • Author(s)
      Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F,
    • Journal Title

      Nat Commun.

      Volume: 6 Issue: 1 Pages: 14470-14470

    • DOI

      10.1038/ncomms14470

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.2016

    • Author(s)
      Koya Y, Kajiyama H, Liu W, Shibata K, Senga T, Kikkawa F.
    • Journal Title

      J Vis Exp.

      Volume: 118 Issue: 118 Pages: 407-414

    • DOI

      10.3791/54353

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.2016

    • Author(s)
      Suzuki S, Sakata J, Utsumi F, Sekiya R, Kajiyama H, Shibata K, Kikkawa F, Nakatsura T.
    • Journal Title

      Oncoimmunology

      Volume: 5 Issue: 11 Pages: e1238542-e1238542

    • DOI

      10.1080/2162402x.2016.1238542

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells.2016

    • Author(s)
      Yoshikawa N, Kajiyama H, Nakamura K, Utsumi F, Niimi K, Mitsui H, Sekiya R, Suzuki S, Shibata K, Callen D, Kikkawa F.
    • Journal Title

      Oncol Rep

      Volume: 35(5) Issue: 5 Pages: 2543-52

    • DOI

      10.3892/or.2016.4653

    • Related Report
      2016 Annual Research Report 2015 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Comparison of prognoses according to non-positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.2016

    • Author(s)
      Maeda O, Miyata-Takata T, Shibata K, Kajiyama H, Mizuno M, Tamakoshi K, Shimoyama Y, Nakamura S, Kikkawa F.
    • Journal Title

      Cancer Med

      Volume: in press Issue: 6 Pages: 1081-1092

    • DOI

      10.1002/cam4.683

    • Related Report
      2016 Annual Research Report 2015 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Variable susceptibility of ovarian cancer cells to non-thermal plasma-activated medium.2016

    • Author(s)
      Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Mizuno M, Toyokuni S, Hori M, Kikkawa F.
    • Journal Title

      Oncol Rep.

      Volume: in press Issue: 6 Pages: 3169-3177

    • DOI

      10.3892/or.2016.4726

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.2015

    • Author(s)
      Yuan H, Kajiyama H, Ito S, Chen D, Shibata K, Hamaguchi M, Kikkawa F, Senga T.
    • Journal Title

      Oncotarget.

      Volume: 30 Pages: 13359-70

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access

URL: 

Published: 2015-04-16   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi